Plasma alpha-glutathione S-transferase assessed as a marker of liver damage in patients with chronic hepatitis C

Clin Chem. 1995 Dec;41(12 Pt 1):1716-9.

Abstract

alpha-Glutathione S-transferase (alpha-GST; EC 2.5.1.18) has been advocated as a better marker of hepatocellular damage than the transaminases in toxic and autoimmune hepatitis. We have assessed the potential interest of plasma alpha-GST determination in 94 anti-hepatitis C virus-positive patients with histologically proven chronic hepatitis C (34 women, 60 men, ages 40.0 +/- 11.9 years). Blood samples were assayed for aspartate aminotransferase (AST), alanine aminotransferase (ALT), gamma-glutamyltransferase, alkaline phosphatase, and alpha-GST on the same day a liver biopsy was performed. alpha-GST concentrations were significantly above reference values in 64% of patients (compared with 58% for AST, 68% for ALT), and this increase was seen in 52% of patients with normal values for transaminases and a Knodell score > 3. Furthermore, there was a significant correlation between alpha-GST and lobular necrosis score (r = 0.31; P < 0.01). Our findings suggest that association of plasma alpha-GST with ALT may improve the biochemical assessment of liver damage in patients with chronic hepatitis C.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Alanine Transaminase / blood
  • Aspartate Aminotransferases / blood
  • Biomarkers
  • Chronic Disease
  • Female
  • Glutathione Transferase / blood*
  • Hepatitis C / enzymology*
  • Hepatitis C / pathology
  • Humans
  • Liver / pathology*
  • Male
  • Middle Aged

Substances

  • Biomarkers
  • Glutathione Transferase
  • Aspartate Aminotransferases
  • Alanine Transaminase